Literature DB >> 10452809

Analysis of the binding of the Fab fragment of monoclonal antibody NC10 to influenza virus N9 neuraminidase from tern and whale using the BIAcore biosensor: effect of immobilization level and flow rate on kinetic analysis.

A A Kortt1, E Nice, L C Gruen.   

Abstract

The binding of the Fab fragment of monoclonal antibody NC10 to influenza virus N9 neuraminidase, isolated from tern and whale, was measured using an optical biosensor. Both neuraminidases, homotetramers of 190 kDa, were immobilized to avoid multivalent binding, and the binding of the monovalent NC10 Fab to immobilized neuraminidase was analyzed using the 1:1 Langmuir binding model. A contribution of mass transport to the kinetic constants was demonstrated at higher surface densities and low flow rates, and was minimized at low ligand densities and relatively high flow rates (up to 100 microl/min). Application of a global fitting algorithm to a 1:1 binding model incorporating a correction term for mass transport indicated that mass transport was minimized under appropriate experimental conditions; analysis of binding data with a mass transport component, using this model, yielded kinetic constants similar to those obtained with the 1:1 Langmuir binding model applied to binding data where mass transport had been minimized experimentally. The binding constant for binding of NC10 Fab to N9 neuraminidase from tern influenza virus (K(A) = 6.3 +/- 1.3 x 10(7) M(-1)) was about 15-fold higher than that for the NC10 Fab binding to N9 neuraminidase from whale influenza virus (K(A) = 4.3 +/- 0.7 x 10(6) M(-1)). This difference in binding affinity was mainly attributable to a 12-fold faster dissociation rate constant of the whale neuraminidase-NC10 Fab complex and may be due to either (i) the long-range structural effects caused by mutation of two residues distant from the binding epitope or (ii) differences in carbohydrate residues, attached to Asn(200), which form part of the binding epitope on both neuraminidases to which NC10 Fab binds. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10452809     DOI: 10.1006/abio.1999.4183

Source DB:  PubMed          Journal:  Anal Biochem        ISSN: 0003-2697            Impact factor:   3.365


  6 in total

1.  Noncovalent scFv multimers of tumor-targeting anti-Lewis(y) hu3S193 humanized antibody.

Authors:  Barbara E Power; Larissa Doughty; Deborah R Shapira; John E Burns; Ann M Bayly; Joanne M Caine; Zhanqi Liu; Andrew M Scott; Peter J Hudson; Alexander A Kortt
Journal:  Protein Sci       Date:  2003-04       Impact factor: 6.725

2.  Mass spectroscopic characterization of the coronavirus infectious bronchitis virus nucleoprotein and elucidation of the role of phosphorylation in RNA binding by using surface plasmon resonance.

Authors:  Hongying Chen; Andrew Gill; Brian K Dove; Stevan R Emmett; C Fred Kemp; Mark A Ritchie; Michael Dee; Julian A Hiscox
Journal:  J Virol       Date:  2005-01       Impact factor: 5.103

3.  Mechanism for the activation of the anaplastic lymphoma kinase receptor.

Authors:  Andrey V Reshetnyak; Paolo Rossi; Alexander G Myasnikov; Munia Sowaileh; Jyotidarsini Mohanty; Amanda Nourse; Darcie J Miller; Irit Lax; Joseph Schlessinger; Charalampos G Kalodimos
Journal:  Nature       Date:  2021-11-24       Impact factor: 69.504

4.  Detailed mechanistic analysis of gevokizumab, an allosteric anti-IL-1β antibody with differential receptor-modulating properties.

Authors:  Hassan Issafras; John A Corbin; Ira D Goldfine; Marina K Roell
Journal:  J Pharmacol Exp Ther       Date:  2013-11-05       Impact factor: 4.030

5.  Interdomain association in fibronectin: insight into cryptic sites and fibrillogenesis.

Authors:  Ioannis Vakonakis; David Staunton; Luke M Rooney; Iain D Campbell
Journal:  EMBO J       Date:  2007-04-26       Impact factor: 11.598

6.  Volume-based solvation models out-perform area-based models in combined studies of wild-type and mutated protein-protein interfaces.

Authors:  Salim Bougouffa; Jim Warwicker
Journal:  BMC Bioinformatics       Date:  2008-10-21       Impact factor: 3.169

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.